NCT03941444 - ANAVEX2-73 Study in Patients With Rett Syndrome | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 6, 2019

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2021

Conditions

Rett Syndrome

Interventions

DRUG

ANAVEX2-73

Liquid oral solution

DRUG

Placebo

Liquid oral solution

Trial Locations (7)

HammondCare, Greenwich

Royal Melbourne Hospital (RMH), Melbourne

The Alfred Hospital, Melbourne

Mater Misericordiae Ltd, South Brisbane

The Keogh Institute for Medical Research, Nedlands

King's College of London, London

Manchester CGM, St. Mary's Hospital, Manchester